iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

SPC Life Sciences gets green signal from SEBI to float IPO

3 Jul 2023 , 03:13 PM

SPC Life Sciences Ltd, a pharmaceutical ingredient company has received SEBI’s approval to raise funds from initial public offer (IPO). The issue consists fresh issuance of equity shares worth Rs 300 crore and an Offer For Sale (OFS) of 89.39 lakh equity shares by promoter, Snehal Rajivbhai Patel as per DRHP.

The pharmaceutical company, which submitted its draft papers to the markets regulator in March, has received an observations letter from the Securities and Exchange Board of India (SEBI) on June 30, indicating approval for its proposed initial public offering (IPO). 

As part of its IPO plans, the company is considering a pre-IPO placement of up to Rs 60 crore. If this placement is successfully completed, it will result in a reduction in the size of the fresh issue.

According to the company’s draft papers, the funds raised from the fresh issue will be utilized for several purposes. These include debt repayment, supporting working capital requirements, funding capital expenditure for the establishment of Phase-2 at its Dahej facility to expand the range of pharmaceutical intermediates, and meeting general corporate expenses.

SPC Life Sciences, based in Gujarat, is a prominent manufacturer of advanced intermediates for important active pharmaceutical ingredients (APIs). These advanced pharmaceutical intermediates play a crucial role in various therapeutic areas, including cardiovascular treatments, vasodilators (anti-platelet medications), anti-psychotic drugs, and anti-depressants.

In addition to SPC Life Sciences, Ratnaveer Precision Engineering Ltd has also received approval from SEBI to proceed with its initial public offering (IPO). 

SPC Life Sciences IPO

Related Tags

  • SPC Life Sciences
  • SPC Life Sciences IPO
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.